SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000882104-16-000141
Filing Date
2016-06-02
Accepted
2016-06-02 12:36:15
Documents
26
Period of Report
2016-06-02
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pdli-201606028xkdoc.htm 8-K 27871
2 PRESENTATION pdli-201606028xkex991.htm EX-99.1 10608
3 slide1a23.jpg GRAPHIC 86150
4 slide2a23.jpg GRAPHIC 246619
5 slide3a23.jpg GRAPHIC 79889
6 slide4a23.jpg GRAPHIC 160952
7 slide5a23.jpg GRAPHIC 111881
8 slide6a23.jpg GRAPHIC 91165
9 slide7a23.jpg GRAPHIC 79308
10 slide8a21.jpg GRAPHIC 159538
11 slide9a18.jpg GRAPHIC 122557
12 slidf63.jpg GRAPHIC 84996
13 slidf64.jpg GRAPHIC 74703
14 slidf65.jpg GRAPHIC 75786
15 slidf66.jpg GRAPHIC 146900
16 slidf67.jpg GRAPHIC 191245
17 slidf68.jpg GRAPHIC 155425
18 slidf69.jpg GRAPHIC 184209
19 slidf70.jpg GRAPHIC 171466
20 slidf71.jpg GRAPHIC 149628
21 slidf72.jpg GRAPHIC 73799
22 slidf73.jpg GRAPHIC 128784
23 slidf74.jpg GRAPHIC 71713
24 slidf75.jpg GRAPHIC 139780
25 slidf76.jpg GRAPHIC 74384
26 slidf77.jpg GRAPHIC 128976
  Complete submission text file 0000882104-16-000141.txt   4159632
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 161691873
SIC: 2836 Biological Products, (No Diagnostic Substances)